Real-world data (RWD) can provide valuable insights into treatment effectiveness and be used to generate evidence for decision-making. Understanding which data, when and how to use it and special considerations when leveraging for regulatory and other stakeholders are all critical to success for RWD comparative effectiveness research (CER). Join Dr. Jessica Paulus as she explores opportunities and challenges with using RWD in conducting CER, including; methods to reduce bias, regulatory considerations, and examples of large real-world datasets and use case applications.
Key learning objectives:
- Explore opportunities and challenges in conducting CER using RWD, including methods to reduce bias
- Identify examples of using large real-world datasets to generate comparative effectiveness insights
- Understand regulatory considerations when using RWD for comparative effectiveness
**Please be advised this webinar is intended primarily for biopharmaceutical and medical device companies. Due to the proprietary nature of the content, vendors and consultants’ registration will automatically be declined. Approval is at the discretion of OM1. Please contact email@example.com with any questions.